Indeed, protective effects of p110δ inhibition in mouse models of asthma, multiple sclerosis, arthritis, and lupus suggest that blockade of effector T cells dominates (Nashed et al., 2007; Durand et al., 2009; Haylock-Jacobs et al., 2011). Here, PIK3CD is linked to systemic lupus erythematosus.